ISSN 1470-2045
Publisher: Elsevier
all issues | next issue >
A shot in the dark pp. 3-3(1)
The Lancet Oncology-Instructions to authors pp. 4-4(1)
Proteomics may aid bladder cancer diagnosis pp. 5-5(1) Author: Sansom C.
Ethics of placebo-controlled trials under discussion pp. 5-5(1) Author: Hutchinson E.
Evidence strengthened for role of BRCA1 in transcription control pp. 6-6(1) Author: Bradbury J.
High risk of cervical cancer in HIV-infected women pp. 6-6(1) Author: Bosch X.
Better prospects for myeloma patients pp. 7-7(1) Author: Bonn D.
Antisense oligonucleotides suppress tumour growth pp. 7-7(1) Author: Habeck M.
New virtual computer on trial pp. 8-8(1) Author: Kenyon G.
Potent anti-cancer drug from witches' umbrella pp. 8-8(1) Author: Stephenson J.
Indian centre develops teletherapy machine for cervical cancer pp. 9-9(1) Author: Sharma D.C.
Melanoma vaccine launch may be too early pp. 9-9(1) Author: Howe M.
Ray of light for treatment of head and neck cancer pp. 10-10(1) Author: Morris K.
Rise and temporary fall of Indian oncology journals pp. 10-10(1) Author: Pai S.A.
A few steps closer to understanding the molecular basis of breast cancer pp. 11-11(1) Author: Senior K.
Hereditary cancer pp. 12-12(1) Authors: Evans G.; Eeles R.
Hereditary cancer - Authors' reply pp. 12-13(2) Authors: Emery J.; Murphy M.; Lucassen A.
PSA assays pp. 13-13(1) Author: Ablin R.J.
Trends in prostate cancer mortality in England, Wales, and the USA pp. 14-14(1) Author: Bishop M.C.
PSA doubling times pp. 14-15(2) Author: Newcombe H.
Importance of field cancerisation in clinical oncology pp. 15-16(2) Authors: Vauthey J.-N.; Walsh G.L.; Vlastos G.; Lauwers G.Y.
Quantitating quality of life pp. 16-16(1) Author: Pritchard J.
Prostate cancer: to screen or not to screen? pp. 17-24(8) Authors: Neal D.E.; Donovan J.L.
Clinical picture - Cutaneous B cell lymphoma arising from a chronically inflamed sebaceous cyst pp. 24-24(1) Authors: Camidge D.; Matheson L.
The role of hypoxia-activated prodrugs in cancer therapy pp. 25-29(5) Author: Denny W.A.
Advances in three-dimensional conformal radiation therapy physics with intensity modulation pp. 30-36(7) Author: Webb S.
Ethnicity and oral cancer pp. 37-42(6) Authors: Scully C.; Bedi R.
Tamoxifen: a personal retrospective pp. 43-49(7) Author: Jordan V.C.
Axel Ullrich - a pioneer in gene technology - Interviewed by Ezzie Hutchinson for The Lancet Oncology pp. 50-53(4)
'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say. pp. 54-55(2) Author: Ernst E.
'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say. pp. 55-56(2) Authors: Cohen L.; Gerner J.; Baile W.
'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say. pp. 56-57(2) Author: Schraub S.
'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say. pp. 57-58(2) Author: Diamond J.
'Alternative cancer cures': looking for common ground - The aim of this occasional feature is to highlight different viewpoints on a controversial issue in oncology, by allowing people (eg clinicians, scientists, nurses and patients) to have their say. pp. 58-59(2) Author: Ross E.
De Libris pp. 60-60(1) Author: Bridgewater J.
De Libris pp. 60-60(1) Author: Boddy A.
De Libris pp. 61-61(1) Author: Jones A.L.
CancerBACUP - a great resource for patients and doctors - www.cancerbacup.org.uk pp. 62-62(1) Author: Patrick T.
Rates and risks - http://rex.nci.nih.gov/NCI_Pub_Interface/raterisk/index.html pp. 62-62(1) Author: Fay M.
New section to Oncolink - http://www.oncolink.upenn.edu/specialty/complementary/ pp. 63-63(1) Author: Hoyland W.
Plumbing the human genome pp. 64-64(1) Author: Lee J.A.